The present results provide a possibility for therapeutic interventions based on the TNF-α-CK2-Hmga2 axis to promote the regeneration of normal hematopoiesis, but also prevent the expansion of MDS stem cells in patients. The gene discussed is HMGA2; the disease is myelodysplastic syndrome.